LivaNova
LIVN
203 hedge funds and large institutions have $3.44B invested in LivaNova in 2021 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 85 reducing their positions, and 29 closing their positions.
10% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 29
10% more capital invested
Capital invested by funds: $3.13B → $3.44B (+$313M)
0.81% more ownership
Funds ownership: 95.35% → 96.16% (+0.81%)
0% more funds holding
Funds holding: 203 → 203 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
36% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 85
60% less call options, than puts
Call options by funds: $3.69M | Put options by funds: $9.13M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
Eminence Capital
New York
|
+$99.4M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$79.9M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$61.5M |
| 4 |
Swedbank
Stockholm,
Sweden
|
+$32.1M |
| 5 |
HRCM
Hawk Ridge Capital Management
Los Angeles,
California
|
+$30.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$40.8M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
-$35.7M |
| 3 |
Goldman Sachs
New York
|
-$32.9M |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$21.7M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$18.8M |
LIVN Hedge Fund Activity: Q1 2021 in Review
203 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in LivaNova (LIVN) for Q1 2021, worth a combined $3.44B — up 10% from $3.13B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new LIVN positions and 29 closed out — a net gain of 3 holders — while 54 added to existing stakes and 85 trimmed.
The largest buyer was Eminence Capital, opening a new position worth an estimated $99.4M. The largest seller was HealthCor Management, exiting entirely with an estimated $40.8M sold.
- 203 institutional investors held LivaNova (LIVN) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $3.44B of LivaNova stock for Q1 2021, up 10% quarter-over-quarter.
- 32 funds opened new LivaNova positions in Q1 2021 and 29 closed out, a net change of +3 holders.
- The largest LivaNova buyer in Q1 2021 was Eminence Capital, an estimated $99.4M added.
- The largest LivaNova seller in Q1 2021 was HealthCor Management, an estimated $40.8M sold.
Based on aggregated 13F filings for Q1 2021.